Acetic acid, Calcium chloride, Dextrose, Magnesium chloride, Potassium chloride, Sodium chloride
Acid Concentrate BP RZ279C
This page is kept for reference and is not offered to search engines.
In other countries
The same active substances on other registers, the same brand first.
- Haemodialysis Concentrate 35 F2 SolutionSaudi Arabia · Pharmaceutical Solution Industries (PSI)Same form
- Haemodialysis Concentrate 35 F2 SolutionSaudi Arabia · Pharmaceutical Solution Industries (PSI)Same form
- Acetate Hemodialysis Cat.No 3-085-005Saudi Arabia · Arabian Diagnostic and Medical CompanySame substance
- XXG & 2DX Bicarbonate Hemodialysis Concentrate "Bicarbolyte"Taiwan · 透析用液劑 · 萬億興業股份有限公司Same substance
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substances
- Acetic acid, Calcium chloride, Dextrose, Magnesium chloride, Potassium chloride, Sodium chloride
- Strength
- 10.81 G / L + 11.58 G / L + 98.99 G / L + 3.431 G / L + 6.710 G / L + 262.98 G / L
- Dosage form
- Liquid
- Route
- Haemodialysis
- Register
- Canada (Health Canada)
- Status
- Cancelled
- Status in the register
- Cancelled Post Market
- Authorised
- 17 Feb 2000
- Registration
- DIN 02240638
- Marketing authorisation holder
- Genpharm Ulc
- ATC code
- B05ZA
- Supply
- ETHICAL